Abstract
Non-Hodgkin lymphomas (NHL) are typical tumors for the pediatric pathologist to be familiar with as they represent around 7–10% of pediatric malignancies, the fourth most common one in children, being more frequent between 15 and 19 years of age (Minard-Colin et al. J Clin Oncol 33(27):2963–2974, 2015; Bollard et al. Pediatr Blood Cancer 60(6):979–984, 2013; Sandlund and Martin Hematology Am Soc Hematol Educ Program. 2016:589–597, 2016). These lymphomas could arise in any tissue, nodal or extranodal, and the pathologist should be prepared to diagnose its histological type according to the updated revised 2016 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (Swerdlow et al. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. IARC, Lyon, 2017).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Minard-Colin V, Brugières L, Reiter A, Cairo MS, Gross TG, Woessmann W, Burkhardt B, Sandlund JT, Williams D, Pillon M, Horibe K, Auperin A, Le Deley MC, Zimmerman M, Perkins SL, Raphael M, Lamant L, Klapper W, Mussolin L, Poirel HA, Macintyre E, Damm-Welk C, Rosolen A, Patte C. Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol. 2015;33(27):2963–74.
Bollard CM, Lim MS, Gross TG, COG Non-Hodgkin Lymphoma Committee. Children’s Oncology Group’s 2013 blueprint for research: non-Hodgkin lymphoma. Pediatr Blood Cancer. 2013;60(6):979–84.
Sandlund JT, Martin MG. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. Hematology Am Soc Hematol Educ Program. 2016;2016(1):589–97.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R. WHO classification of tumours of haematopoietic and lymphoid tissues, revised. 4th ed. Lyon: IARC; 2017.
Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M, European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Study Group. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents. Haematologica. 2016;101(12):1581–91.
Citrin R, Horowitz JP, Reilly AF, Li Y, Huang YS, Getz KD, Seif AE, Fisher BT, Aplenc R. Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database. PLoS One. 2017;12(10):e0186960.
Deeney S, Stewart C, Treece AL, Black JO, Lovell MA, Garrington T, Karrer F, Bruny J. Diagnostic utility of core needle biopsy versus open wedge biopsy for pediatric intraabdominal solid tumors: Results of a prospective clinical study. J Pediatr Surg. 2017;52(12):2042–6.
Blondiaux E, Laurent M, Audureau E, Boudjemaa S, Sileo C, Lenoir M, Dainese L, Garel C, Coulomb A, Ducou le Pointe H. Factors influencing the diagnostic yield and accuracy of image-guided percutaneous needle biopsy of pediatric tumors: single-center audit of a 26-year experience. Pediatr Radiol. 2016;46(3):372–82.
Rohde M, Bonn BR, Zimmermann M, Lange J, Möricke A, Klapper W, Oschlies I, Szczepanowski M, Nagel I, Schrappe M, MMML-MYC-SYS Project, ICGC MMML-Seq Project, Loeffler M, Siebert R, Reiter A, Burkhardt B. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols. Haematologica. 2017;102(6):1091–8.
Bobée V, Ruminy P, Marchand V, Viailly PJ, Abdel Sater A, Veresezan L, Drieux F, Bérard C, Bohers E, Mareschal S, Dubois S, Jais JP, Leroy K, Figeac M, Picquenot JM, Molina TJ, Salles G, Haioun C, Tilly H, Jardin F. Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM Study. J Mol Diagn. 2017;19(6):892–904.
Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci Transl Med. 2016;8(364):364ra155.
Acknowledgments
Acknowledgments to Julie Bruneau, Danielle Canioni, Josette Brière, Sophie Kaltenbach, Isabelle Radford Weiss, Serge Romana, Elizabeth MacIntyre, Vahid Asnafi, Ludovic Lhermitte, and Chantal Brouzes for the fruitful and constant laboratory interaction in the multidisciplinary approach of pediatric lymphoid disorders diagnosis as well as Véronique Minard, Laurence Brugières, Bénédicte Neven, Despinha Moshous, and Comité Lymphome of SFCE for their crucial interaction considering the clinical part of the classification.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Molina, T.J. (2019). Diagnosis and Classification. In: Abla, O., Attarbaschi, A. (eds) Non-Hodgkin's Lymphoma in Childhood and Adolescence. Springer, Cham. https://doi.org/10.1007/978-3-030-11769-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-11769-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11768-9
Online ISBN: 978-3-030-11769-6
eBook Packages: MedicineMedicine (R0)